AI21 Labs develops generative AI systems that utilize advanced foundation models and a built-in Retrieval-Augmented Generation (RAG) engine to create conversational AI applications grounded in enterprise data. Their technology enhances enterprise workflows by providing accurate, reliable, and scalable AI solutions tailored to specific organizational needs.

Ambi Robotics develops AI-powered robotic systems for small parcel sorting, utilizing modular induction and sorting technology to enhance operational efficiency in e-commerce logistics. Their solutions achieve over 99% sorting accuracy and can process more than 500 parcels per hour, significantly reducing sorting costs and improving throughput.

Bicycle Therapeutics creates fully synthetic, bi‑cyclic peptide molecules that combine the high affinity of biologics with drug‑like pharmacokinetics, enabling precise targeting of protein‑protein interactions that are difficult for traditional small molecules or antibodies. Their platform delivers rapid tissue penetration, renal clearance, and flexible conjugation to payloads, supporting targeted drug conjugates and immune agonists for solid‑tumor oncology and a range of non‑oncology indications. The company partners with pharma, biotech, and academic groups to develop novel therapeutics for high‑unmet‑need disease targets.

biomodal develops the duet multiomics solution evoC, which captures both genetic and epigenetic data from a single 5ng DNA sample in one sequencing run, enabling the analysis of 5-methylcytosine and 5-hydroxymethylcytosine alongside the four canonical bases. This technology addresses the limitations of current sequencing methods that fail to provide comprehensive insights from low-input samples, enhancing applications in cancer research, neurodegenerative disease, and precision medicine.

Bitfount provides a federated AI and data science platform enabling secure collaboration across life sciences and clinical research organizations. The platform allows algorithms to run directly on distributed data sources, such as imaging and EHR systems, without requiring data extraction or sharing. This facilitates faster patient recruitment, site feasibility analysis, and cross-silo AI development while maintaining data privacy and security behind the firewall.

Cellarity utilizes AI and single-cell omics data to develop therapies targeting cellular dysfunction, enabling the creation of medicines for diseases that traditional drug discovery methods cannot address. Their platform integrates biological and chemical insights with multi-omics data to enhance the precision of therapeutic design.

Constructive.Bio utilizes a dual-technology platform that combines de novo genome synthesis and engineered translation to create programmable biomolecules with high fidelity. This approach addresses the limitations of traditional biomanufacturing by enabling the production of customized bioproducts, including phage-resistant strains and next-generation therapeutics.

Edifice Health provides the Inflammatory Age® test, a biomarker composite scoring system developed from a decade-long NIH-funded study, to measure and monitor systemic chronic inflammation. This technology enables healthcare providers to identify and manage chronic inflammation, which is linked to age-related diseases and overall health deterioration.

Graphcore designs and manufactures Intelligence Processing Units (IPUs) and the Poplar software stack to accelerate machine learning workloads. Their technology enables faster training and inference for complex AI models across various industries. IPUs are optimized for the parallel processing demands of deep learning, offering a distinct advantage for AI innovation.

Heirloom is a web‑based platform that lets professionals create and join purpose‑driven decentralized autonomous organizations (DAOs) for startups, nonprofits, or creative collectives. It provides one‑click DAO creation, integrated proposal voting, task management, and capital‑raising tools while abstracting blockchain complexity, enabling distributed teams to collaborate, govern, and fund ventures transparently.

MenteeBot develops personalized, AI-based robotic platforms designed for user interaction and mentorship. These autonomous systems utilize advanced artificial intelligence to adapt and learn from user input. The platform offers a unique, non-teleoperated approach to human-robot engagement.

MIRAI is an AI-powered computer vision platform that enables industrial robots to detect objects, estimate pose, and adjust trajectories in real time without CAD models or manual calibration. It handles reflective, transparent, and dirty parts, integrates via OPC‑UA and ROS APIs, and allows on‑site model retraining to support high‑mix, low‑volume production.

Mogrify develops in vivo reprogramming therapies that utilize a proprietary platform to identify key transcriptomic and epigenetic factors necessary for direct cellular conversion. This technology aims to restore lost cell types in patients with degenerative diseases, particularly in otology, ophthalmology, and diabetes, addressing significant unmet clinical needs.

Nu Quantum is developing the Entanglement Fabric, a networking architecture that integrates Quantum Processing Units through a Qubit-Photon Interface to create scalable, entangled qubit networks. This technology enables datacentre-scale quantum computing by facilitating modular hardware and software scaling, addressing the need for significantly more powerful quantum compute systems.

OutSee develops computational algorithms for genomic analysis to identify therapeutic targets for precision medicine. The company enhances drug discovery by providing accurate insights into genetic variations that influence treatment efficacy.

Ovo Labs develops therapeutics to improve egg quality and IVF success rates by addressing age-related declines in oocyte quality. Their pipeline targets molecular mechanisms that cause chromosome segregation errors, aiming to enhance fertility outcomes for women undergoing treatment.

Phaidra develops AI-driven control systems that utilize deep reinforcement learning to optimize operations in mission-critical facilities, enhancing stability, energy efficiency, and sustainability. By replacing static, hard-coded control systems, Phaidra's technology continuously adapts and improves, significantly reducing energy consumption and CO2 emissions in industrial environments.

The startup has developed a universal testing platform that utilizes single-molecule fluorescent microscopy combined with machine learning for the digital imaging-based identification of infectious diseases. This technology enables rapid and accurate detection of unknown respiratory virus infections, enhancing diagnostic capabilities for healthcare providers.

Rubedo Life Sciences is a clinical-stage biotech company focused on developing therapeutics that target the pathologic cells driving aging. The company utilizes its Alembic discovery platform to identify novel drug candidates aimed at promoting biological youthfulness. Their pipeline includes GPX4 modulators designed to address chronic diseases associated with the aging process.

Jaxtr is a platform that provides a curated selection of technology products for children, including computers, mobile phones, and educational tools. The company addresses the challenge of finding age-appropriate and safe technology options for kids, ensuring parents can easily access reliable and suitable devices for their children's needs.

The startup offers a cloud-based platform that provides quoting and enrollment services for Medicare Advantage, prescription drug, and supplement plans tailored for health planners and brokers. This technology enables clients, including call centers and field marketing organizations, to streamline their operations and enhance efficiency in managing supplement plans.

Switchback Systems has developed a scalable benchtop DNA synthesis platform that integrates oligonucleotide synthesis and gene assembly capabilities, significantly reducing the time, cost, and waste associated with traditional DNA synthesis methods. This technology empowers scientists across various industries, including pharmaceuticals and agriculture, to efficiently produce custom DNA sequences for research and development.

Zapata provides an end‑to‑end quantum computing platform that combines a multi‑language SDK, a curated library of quantum algorithms, and integrated access to major quantum hardware, together with a high‑fidelity simulator for pre‑hardware testing. The platform’s hybrid workflow engine automates quantum‑classical pipelines and includes security‑focused data handling, while its consulting services help enterprises map use cases, develop roadmaps, and train staff to accelerate quantum adoption.

ZOE offers an at‑home gut microbiome and blood‑marker test that uses shotgun metagenomic sequencing and proprietary machine‑learning models to predict each user’s post‑meal glucose and triglyceride responses. Its AI‑powered mobile app provides real‑time food scanning, personalized nutrition scores, plant‑diversity tracking, and a whole‑food supplement, with HIPAA‑compliant cloud storage and optional FHIR integration for health‑record syncing.